106 related articles for article (PubMed ID: 17278500)
1. Robust experiment design for estimating myocardial beta adrenergic receptor concentration using PET.
Salinas C; Muzic RF; Ernsberger P; Saidel GM
Med Phys; 2007 Jan; 34(1):151-65. PubMed ID: 17278500
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of myocardial beta-adrenergic receptors with fluorocarazolol: lack of interference by endogenous catecholamines.
Salinas C; Muzic RF; Berridge M; Ernsberger P
J Cardiovasc Pharmacol; 2005 Aug; 46(2):222-31. PubMed ID: 16044035
[TBL] [Abstract][Full Text] [Related]
3. Iterative optimal design of PET experiments for estimating beta-adrenergic receptor concentration.
Muzic RF; Saidel GM; Zhu N; Nelson AD; Zheng L; Berridge MS
Med Biol Eng Comput; 2000 Nov; 38(6):593-602. PubMed ID: 11217875
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, binding properties, and 18F labeling of fluorocarazolol, a high-affinity beta-adrenergic receptor antagonist.
Zheng L; Berridge MS; Ernsberger P
J Med Chem; 1994 Sep; 37(20):3219-30. PubMed ID: 7932549
[TBL] [Abstract][Full Text] [Related]
5. Characterization of pulmonary and myocardial beta-adrenoceptors with S-1'-[fluorine-18]fluorocarazolol.
Visser TJ; van Waarde A; van der Mark TW; Kraan J; Elsinga PH; Pruim J; Ensing K; Jansen T; Willemsen AT; Franssen EJ; Visser GM; Paans AM; Vaalburg W
J Nucl Med; 1997 Feb; 38(2):169-74. PubMed ID: 9025729
[TBL] [Abstract][Full Text] [Related]
6. Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy.
Tsukamoto T; Morita K; Naya M; Inubushi M; Katoh C; Nishijima K; Kuge Y; Okamoto H; Tsutsui H; Tamaki N
J Nucl Med; 2007 Nov; 48(11):1777-82. PubMed ID: 17942801
[TBL] [Abstract][Full Text] [Related]
7. Optimal experiment design for PET quantification of receptor concentration.
Muzic RF; Nelson AD; Saidel GM; Miraldi F
IEEE Trans Med Imaging; 1996; 15(1):2-12. PubMed ID: 18215884
[TBL] [Abstract][Full Text] [Related]
8. Are [O-methyl-11C]derivatives of ICI 89,406 beta1-adrenoceptor selective radioligands suitable for PET?
Law MP; Wagner S; Kopka K; Pike VW; Schober O; Schäfers M
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):174-85. PubMed ID: 17906860
[TBL] [Abstract][Full Text] [Related]
9. Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388.
de Jong RM; Willemsen AT; Slart RH; Blanksma PK; van Waarde A; Cornel JH; Vaalburg W; van Veldhuisen DJ; Elsinga PH
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):443-7. PubMed ID: 15592928
[TBL] [Abstract][Full Text] [Related]
10. Specific beta-adrenergic receptor binding of carazolol measured with PET.
Berridge MS; Nelson AD; Zheng L; Leisure GP; Miraldi F
J Nucl Med; 1994 Oct; 35(10):1665-76. PubMed ID: 7931670
[TBL] [Abstract][Full Text] [Related]
11. Validation of S-1'-[18F]fluorocarazolol for in vivo imaging and quantification of cerebral beta-adrenoceptors.
Doze P; Van Waarde A; Elsinga PH; Van-Loenen Weemaes AM; Willemsen AT; Vaalburg W
Eur J Pharmacol; 1998 Jul; 353(2-3):215-26. PubMed ID: 9726651
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy.
Merlet P; Delforge J; Syrota A; Angevin E; Mazière B; Crouzel C; Valette H; Loisance D; Castaigne A; Randé JL
Circulation; 1993 Apr; 87(4):1169-78. PubMed ID: 8096441
[TBL] [Abstract][Full Text] [Related]
13. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
[TBL] [Abstract][Full Text] [Related]
14. In vivo quantification and parametric images of the cardiac beta-adrenergic receptor density.
Delforge J; Mesangeau D; Dolle F; Merlet P; Loc'h C; Bottlaender M; Trebossen R; Syrota A
J Nucl Med; 2002 Feb; 43(2):215-26. PubMed ID: 11850488
[TBL] [Abstract][Full Text] [Related]
15. Consequences of labetalol administration on myocardial beta adrenergic receptors in the brain dead pig.
Seguin C; Devaux Y; Aubert N; Siaghy EM; Zannad F; Burlet C; Ungureanu-Longrois D; Mertes PM
Ann Transplant; 2000; 5(4):54-60. PubMed ID: 11499363
[TBL] [Abstract][Full Text] [Related]
16. Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses.
El Fakhri G; Sitek A; Guérin B; Kijewski MF; Di Carli MF; Moore SC
J Nucl Med; 2005 Aug; 46(8):1264-71. PubMed ID: 16085581
[TBL] [Abstract][Full Text] [Related]
17. Acute myocardial beta-adrenergic receptor dysfunction after cardiopulmonary bypass in patients with cardiac valve disease. Duke Heart Center Perioperative Desensitization Group.
Gerhardt MA; Booth JV; Chesnut LC; Funk BL; el-Moalem HE; Kwatra MM; Schwinn DA
Circulation; 1998 Nov; 98(19 Suppl):II275-81. PubMed ID: 9852914
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cardiac beta-adrenoreceptors in the isolated perfused rat heart using (S)-11C-CGP12388.
Momose M; Reder S; Raffel DM; Watzlowik P; Wester HJ; Nguyen N; Elsinga PH; Bengel FM; Remien J; Schwaiger M
J Nucl Med; 2004 Mar; 45(3):471-7. PubMed ID: 15001690
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cardiac beta-adrenergic receptors in the guinea pig heart: application to study of beta-adrenergic receptors in shock models.
Kaufman TM; Horton JW
J Surg Res; 1993 Nov; 55(5):516-23. PubMed ID: 8231171
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and first in vivo evaluation of new selective high affinity beta1-adrenoceptor radioligands for SPECT based on ICI 89,406.
Wagner S; Kopka K; Law MP; Riemann B; Pike VW; Schober O; Schäfers M
Bioorg Med Chem; 2004 Aug; 12(15):4117-32. PubMed ID: 15246089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
